aspirin has been researched along with Cancer of Cervix in 11 studies
Aspirin: The prototypical analgesic used in the treatment of mild to moderate pain. It has anti-inflammatory and antipyretic properties and acts as an inhibitor of cyclooxygenase which results in the inhibition of the biosynthesis of prostaglandins. Aspirin also inhibits platelet aggregation and is used in the prevention of arterial and venous thrombosis. (From Martindale, The Extra Pharmacopoeia, 30th ed, p5)
acetylsalicylate : A benzoate that is the conjugate base of acetylsalicylic acid, arising from deprotonation of the carboxy group.
acetylsalicylic acid : A member of the class of benzoic acids that is salicylic acid in which the hydrogen that is attached to the phenolic hydroxy group has been replaced by an acetoxy group. A non-steroidal anti-inflammatory drug with cyclooxygenase inhibitor activity.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Outcomes included 6 clinical quality measures of being up to date for colorectal cancer screening, cervical cancer screening, tobacco screening and cessation counseling, BMI screening and follow-up, depression screening and follow-up, and aspirin use for ischemic vascular disease." | 4.31 | The First Year of the COVID-19 Pandemic: Changes in Preventive Services in Community Health Centers. ( Bandi, P; Han, X; Jemal, A; Makaroff, LA; Minihan, AK; Star, J, 2023) |
| "Acetaminophen use was not associated with the risk of cervical cancer." | 1.42 | Aspirin and Acetaminophen Use and the Risk of Cervical Cancer. ( Cannioto, RA; Friel, G; Hampras, SS; Kolomeyevskaya, NV; Kruszka, B; Lele, SB; Liu, CS; Moysich, KB; Odunsi, KO; Schmitt, K, 2015) |
| "Viability of cervical cancer cell lines was assessed by the MTT method at various concentrations of aspirin and triptolide." | 1.39 | Enhanced anti-tumor efficacy of aspirin combined with triptolide in cervical cancer cells. ( Chen, RH; Tian, YJ, 2013) |
| "However, there are few reports about cervical cancer." | 1.36 | Aspirin inhibits ErbB2 to induce apoptosis in cervical cancer cells. ( He, Q; Sun, Z; Wang, Y; Xiang, S; Yan, F; Zhang, J, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (9.09) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 7 (63.64) | 24.3611 |
| 2020's | 3 (27.27) | 2.80 |
| Authors | Studies |
|---|---|
| Star, J | 1 |
| Han, X | 1 |
| Makaroff, LA | 1 |
| Minihan, AK | 1 |
| Jemal, A | 1 |
| Bandi, P | 1 |
| Das, S | 3 |
| Ray, DK | 3 |
| Sengupta, D | 3 |
| Mahapatra, E | 3 |
| Biswas, S | 3 |
| Roy, M | 3 |
| Mukherjee, S | 3 |
| Zárate, GDSF | 1 |
| Flores, FLR | 1 |
| Burguete, AI | 1 |
| Marina, VM | 1 |
| Olea, EG | 1 |
| Carranza, CO | 1 |
| Melendrez, CG | 1 |
| Morales, VHB | 1 |
| Tuyaerts, S | 1 |
| Van Nuffel, AMT | 1 |
| Naert, E | 1 |
| Van Dam, PA | 1 |
| Vuylsteke, P | 1 |
| De Caluwé, A | 1 |
| Aspeslagh, S | 1 |
| Dirix, P | 1 |
| Lippens, L | 1 |
| De Jaeghere, E | 1 |
| Amant, F | 1 |
| Vandecasteele, K | 1 |
| Denys, H | 1 |
| Xie, LX | 1 |
| Hu, LN | 1 |
| Chen, HX | 1 |
| Peng, X | 1 |
| Li, JK | 1 |
| Chen, RH | 1 |
| Tian, YJ | 1 |
| Wilson, JC | 1 |
| O'Rorke, MA | 1 |
| Cooper, JA | 1 |
| Murray, LJ | 1 |
| Hughes, CM | 1 |
| Gormley, GJ | 1 |
| Anderson, LA | 1 |
| Friel, G | 1 |
| Liu, CS | 1 |
| Kolomeyevskaya, NV | 1 |
| Hampras, SS | 1 |
| Kruszka, B | 1 |
| Schmitt, K | 1 |
| Cannioto, RA | 1 |
| Lele, SB | 1 |
| Odunsi, KO | 1 |
| Moysich, KB | 1 |
| Xiang, S | 1 |
| Sun, Z | 1 |
| He, Q | 1 |
| Yan, F | 1 |
| Wang, Y | 1 |
| Zhang, J | 1 |
| Im, SR | 1 |
| Jang, YJ | 1 |
| Mennie, AT | 1 |
| Dalley, VM | 1 |
| Dinneen, LC | 1 |
| Collier, HO | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Phase II Investigation of Pembrolizumab (Keytruda) in Combination With Radiation and an Immune Modulatory Cocktail in Patients With Cervical and Uterine Cancer (PRIMMO Trial)[NCT03192059] | Phase 2 | 43 participants (Actual) | Interventional | 2017-07-01 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
3 trials available for aspirin and Cancer of Cervix
| Article | Year |
|---|---|
PRIMMO study protocol: a phase II study combining PD-1 blockade, radiation and immunomodulation to tackle cervical and uterine cancer.
Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Aspirin; Chemoradiotherapy; Curcumin; Cycl | 2019 |
Non-steroidal anti-inflammatory drug use and cervical cancer risk: a case-control study using the Clinical Practice Research Datalink.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Case-C | 2013 |
Treatment of radiation-induced gastrointestinal distress with acetylsalicylate.
Topics: Antacids; Aspirin; Buffers; Clinical Trials as Topic; Diarrhea; Drug Combinations; Drug Evaluation; | 1975 |
8 other studies available for aspirin and Cancer of Cervix
| Article | Year |
|---|---|
The First Year of the COVID-19 Pandemic: Changes in Preventive Services in Community Health Centers.
Topics: Aspirin; Colorectal Neoplasms; Community Health Centers; COVID-19; Early Detection of Cancer; Female | 2023 |
Aspirin Restores Radiosensitivity in Cervical Cancer Cells by Inducing Mitotic Catastrophe through Downregulating G2/M Effectors.
Topics: Apoptosis; Aspirin; Aurora Kinase A; Cell Line, Tumor; Female; G2 Phase Cell Cycle Checkpoints; Huma | 2022 |
Aspirin Restores Radiosensitivity in Cervical Cancer Cells by Inducing Mitotic Catastrophe through Downregulating G2/M Effectors.
Topics: Apoptosis; Aspirin; Aurora Kinase A; Cell Line, Tumor; Female; G2 Phase Cell Cycle Checkpoints; Huma | 2022 |
Aspirin Restores Radiosensitivity in Cervical Cancer Cells by Inducing Mitotic Catastrophe through Downregulating G2/M Effectors.
Topics: Apoptosis; Aspirin; Aurora Kinase A; Cell Line, Tumor; Female; G2 Phase Cell Cycle Checkpoints; Huma | 2022 |
Aspirin Restores Radiosensitivity in Cervical Cancer Cells by Inducing Mitotic Catastrophe through Downregulating G2/M Effectors.
Topics: Apoptosis; Aspirin; Aurora Kinase A; Cell Line, Tumor; Female; G2 Phase Cell Cycle Checkpoints; Huma | 2022 |
Low-Dose Aspirin Has Antiproliferative and Apoptosis Effects in HPV16 Tumor Cells and Delays Tumor Development and Growth in an Experimental Model.
Topics: Animals; Apoptosis; Aspirin; Cell Line, Tumor; Cell Proliferation; Female; Human papillomavirus 16; | 2023 |
[Effects of NF-kappaB inhibitor on cisplatin-induced apoptosis in cervical cancer].
Topics: Apoptosis; Aspirin; Cell Cycle; Cell Line, Tumor; Cell Survival; Cisplatin; Curcumin; Female; Humans | 2013 |
Enhanced anti-tumor efficacy of aspirin combined with triptolide in cervical cancer cells.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents, Alkylating; Apoptosis; Aspirin; bcl- | 2013 |
Aspirin and Acetaminophen Use and the Risk of Cervical Cancer.
Topics: Acetaminophen; Adenocarcinoma; Adult; Aged; Analgesics, Non-Narcotic; Anti-Inflammatory Agents, Non- | 2015 |
Aspirin inhibits ErbB2 to induce apoptosis in cervical cancer cells.
Topics: Apoptosis; Aspirin; Cell Line, Tumor; Cell Survival; Female; HeLa Cells; Humans; Proto-Oncogene Mas; | 2010 |
Aspirin enhances TRAIL-induced apoptosis via regulation of ERK1/2 activation in human cervical cancer cells.
Topics: Apoptosis; Aspirin; Caspases; Enzyme Activation; Female; HeLa Cells; Humans; MAP Kinase Signaling Sy | 2012 |